go to contents

Life Sciences Directory

Results

usePAT GmbH

usePAT offers add-on devices for the improvement of in-line measurements in PAT (Process Analytical Technology) systems. They are compatible with a variety of sensors and can be designed and adapted to the specific needs and requirements of many fields of application. In order to facilitate the process of real-time measuring, our technology takes advantage of well-controlled ultrasonic fields for spatial particle manipulation in liquids.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
non-specific applications
Focus
other
laboratory equipment

ingenetix GmbH

Core areas of expertise are design, development and production of real-time PCR-based tests for the detection of various pathogens such as bacteria, viruses, fungi and parasites, for applications in human and veterinary medicine.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
non-specific applications
Focus
measurement and sensor technology

Pregenerate GmbH

Pregenerate GmbH is a Vienna- based medtech startup established in November, 2019 with an aim to improve treatment outcomes for osteoarthritis patients by in vitro monitoring of cellular responses to different therapeutics. The Pregenerate team consists of five full time employees with extensive academic and clinical experience, as well as years of expertise in the pharmaceutical industry.

Organization type
RDM biotech/pharma
Region
Vienna
Focus
bioinformatics
Focus
other
consumables / reagents
plastic machining and processing
laboratory equipment

enGenes Biotech GmbH

enGenes Biotech develops customized solutions for the cost-effective production of recombinant proteins and plasmid DNA in microbial expression systems. The company’s unique, proprietary, E. coli-based enGenes-X-press technology platform achieves outstanding yields of soluble and active recombinant protein or plasmid DNA by reducing biological complexity. This is achieved by decoupling biomass growth from product formation.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
industrial processing
Focus
consumables / reagents

ProFem GmbH

Based on a highly innovative therapeutic concept ProFem develops new medicines for gynecological diseases which are characterized by a hitherto unmet medical need and high market potential. ProFem’s activities are currently focused on infectious diseases of the female lower genitourinary tract associated with the growth of biofilms.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

VelaLabs GmbH

VelaLabs services as a GLP and GMP certified and G(C)LP compliant contract laboratory cover analytical services for Biologics (ATMPs, Biopharmaceuticals, Originator products, Biosimilar Candidates, Biosimilars, Blood and blood components, Vaccines), Chemicals and Excipients from early stages of product development (non-clinical, clinical) until market release testing for Pharma and Biotech companies as well as storage facilities enabling long term stability studies.
 

Organization type
service provider
Region
Vienna
Cluster
LISAvienna
Human.technology Styria
Focus
non-specific applications
human health
Offer
contract research / clinical research
accredited laboratory

Boehringer Ingelheim RCV GmbH

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
industrial processing

Allcyte GmbH

Allcyte is a pioneer in the field of functional precision oncology. The company provides actionable data on the activity of drug candidates directly in live tissue samples of human cancer patients to support strategic R

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Focus
other

DIPHA GmbH

Technology transfer, pharmaceutical development for solid dosage forms (tablet, granulates, a.o.) for clinical studies, liquids and creams. Study development and monitoring (Phase I-II), CRO biomarker development for inflammatory and autoimmun diseases, product management for pharmacies, licensing and marketing

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health / animal health
Offer
contract research / clinical research
other
contract manufacturing
Focus
other

Proxygen GmbH

Proxygen harnesses the cellular protein quality control system to develop therapies against cancer and other life-threatening diseases. We are focused on particular small molecules called “molecular glue degraders” which mediate recruitment of a disease-causing protein to a ubiquitin ligase where it is ubiquitinated and directed to the proteasome for degradation. Hence, instead of merely blocking the function of harmful proteins, molecular glue degraders enable their complete and selective elimi

Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

APEIRON Biologics AG

APEIRON Biologics AG at a glance: APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. APEIRON Biologics´ projects and technologies are based on a strong patent portfolio and partnerships with leading pharmaceutical companies and academic institutions.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Hookipa Biotech AG

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on its proprietary arenavirus platform that reprograms the body’s immune system.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

a:head bio AG

a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids

Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Evercyte GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
non-specific applications

Syconium Lactic Acid GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
industrial processing

Origimm Biotechnology GmbH

Origimm (‘Origins of immunity’) is a biotech company that specializes in the discovery of antigens and dermatological drug targets. The company uses its proprietary technology that employs reverse functional screening to discover and develop breakthrough therapies for the prevention and treatment of skin microbiome-associated diseases such as acne vulgaris and other microbiome-associated infections.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Accanis Biotech F

What if we could give the body instructions to produce its own drugs? This would be nothing less than a new era in drug therapy and is exactly what messenger RNA (mRNA) could achieve. At ACCANIS, we develop innovative therapeutics for the treatment of common, localized diseases using mRNA. Each cell in your body uses mRNA to translate genetic information into proteins. ACCANIS´ innovative technology takes advantage of this natural mechanism in order to enable effective, on-demand therapeutics.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Miti Biosystems GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Vivaldi Biosciences AG

Vivaldi Biosciences is developing its DeltaFLU influenza vaccine to provide broad cross-protection and superior efficacy in the prophylaxis of seasonal and pandemic influenza. DeltaFLU is composed of influenza vaccine strains genetically modified by deletion of the gene for nonstructural protein 1.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

PLANTA Naturstoffe Vertriebsges.m.b.H.

Planta was founded in 1994 by three dynamic biotechnologists whose aim was to put their ideas and visions into practice. Today Planta is an innovative drug development company. Our staff members’ academic backgrounds lie in the fields of biochemistry, biology, pharmacology and toxicology. Our permanent key personal consists of seven co-workers – a group which allows for a compact and familiar atmosphere. Flexibility is our strength and is a great asset to our customers and cooperation partners.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Filter
Reset filter